Resveratrol treatment results in activation of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) by SIRT1, which prevents development of diet-induced obesity and insulin resistance [137]. The gene discussed is PPARGC1A; the disease is obesity due to melanocortin 4 receptor deficiency.